Here we present a rare combination of aortobronchial fistula and endograft infection after repeat endovascular aortic repair. Device retention, debridement and negative pressure wound therapy, in combination with suppressive antimicrobial therapy, led to satisfactory control of infection until the patient died due to another complication. The combination of an aortobronchial fistula and endograft infection has never been described before. This present case should encourage and show clinicians the importance of an interdisciplinary approach in highly difficult clinical courses.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059411 | PMC |
| http://dx.doi.org/10.1136/bcr-2019-229924 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Objective: The aim of the study was to summarize epidemiologic data about aortobronchial fistulas and compare outcomes (mortality, recurrence, re-operation) of open, staged, and endovascular repair of aortobronchial fistula.
Methods: A systematic literature review was conducted to identify eligible studies published between January of 1999 and December of 2019. The Cochrane Library, PubMed and Scopus databases were used as search engines.
Thoracic endovascular aortic repair (TEVAR) explantation and left lower lobectomy for aortobronchial fistula repair.
JTCVS Tech
October 2024
Department of Cardiothoracic Surgery, Emory University Hospitals, Atlanta, Ga.
Outcomes of Endovascular Treatment for Infectious Thoracic Aortic Diseases.
J Vasc Interv Radiol
January 2025
Department of Radiology, Mie University Hospital, Tsu, Mie, Japan.
Purpose: To investigate the effectiveness and safety of thoracic endovascular aortic repair (TEVAR) for infectious aortic diseases.
Materials And Methods: Patients who underwent TEVAR for infectious aortic diseases including infected thoracic aortic aneurysm, aortobronchial fistula (ABF), and aortoenteric fistula from December 2011 to October 2022 at 4 institutions were retrospectively studied. The primary outcome of the study was overall survival, whereas the secondary outcome was comprehensive adverse events.
Cause of death for heart transplant patients, an autopsy study.
Cardiovasc Pathol
November 2024
Department of Pathology and Immunology, Washington University in St. Louis School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA. Electronic address:
Article Synopsis
- Heart transplantations are critical for patients with severe heart failure, but understanding complications and causes of death post-transplant is essential for improving patient care.
- A comprehensive review of autopsies from 1990 to 2023 revealed demographic data, clinical histories, and causes of death in 88 heart transplant patients.
- The study identified significant findings, including that 41.1% of deaths were related to the transplant operation, while 58.9% were due to other factors, with some unexpected causes not recognized before death.
Staged complex reconstruction of infected thoracic aortic endograft and adjacent spinal hardware using latissimus wrapped lateral aortic graft.
J Vasc Surg Cases Innov Tech
December 2024
Division of Vascular Diseases and Surgery, Department of Surgery, The Ohio State University Wexner Medical Center, Columbus, OH.
Thoracic endovascular aortic repair (TEVAR) enables rapid and effective treatment of life-threatening aortic injuries. The occurrence of long-term complications from TEVAR and their management is ill-defined in young patients. This report describes a complex case of a 38-year-old male patient who underwent staged interventions for different acute pathologies instigated by blunt thoracic spinal trauma.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!